17 stories about AstraZeneca

AstraZeneca, Accenture, AWS and Clalit Health Services launch BeyondBio SCALE startup program

02.08.22|James Spiro
The program is expected to start in November and run until next summer, and will assist startups to expand into markets with the help of program collaborators and their clinical, commercial, and technical expertise
אראל מרגלית, אוהד גולדברג ושמעון אלקבץ

The digital health revolution: PlayBeyondBio’s startup cohort comes to a close

06.04.22|Doron Broitman
The program, led by AstraZeneca, the JVP venture capital fund, the international consulting firm Accenture, Margalit Startup City, Amazon Web Services (AWS) and Shaare Zedek Medical Center in Jerusalem, lasted for six months and included eight startups
Anna Pellivert Yissum Technology

To spur innovation, tech ecosystems can’t afford to overlook academia

09.08.21|Anna Pellivert
Curiosity Driven Research born from academia is vital in order to keep the best minds tackling the biggest questions in science.
PlayBeyondBio Team

PlayBeyondBio begins second cohort looking for health solutions in a post-Covid world

03.06.21|James Spiro
The initiative is being run by AstraZeneca, JVP, Accenture, and Margalit Startup City
אהרון אהרון מנכ'ל רשות החדשנות 30.9.20

Pfizer, AstraZeneca, Merck, and Teva win tender for new Israeli Innovation Lab

27.12.20|James Spiro
The lab, which is set to research digital health and computational biology, has a government budget of $9.9 million
רן קורבר

Israeli medical-device startup offers a breath of fresh air

24.12.20|Yafit Ovadia
BreezoMeter wants to monitor the air you breath, and has developed a platform to keep track of air quality to help those with lung conditions
            תחנת חיסון קורונה קופת חולים מכבי

Will the quickly developed vaccines deliver Covid-19 a knockout blow?

13.12.20|Sophie Shulman
An urgent global crisis, near-limitless funds, and a scientific development ripe for use combined to produce rapid results, but will today’s vaccines eradicate the pandemic?
כיתוב אוניברסיטת ת"א פרופ גרשוני

New innovative vaccines by Moderna and Pfizer are safe, says top Israeli virologist

24.11.20|Yafit Ovadia
“There isn’t any need for alarm,” says virologist about new coronavirus vaccines
צוות פליי ביונד

PlayBeyondBio Program: Corona vaccine developer, AstraZeneca, selects two Israeli startups for investment

22.11.20|By PlayBeyondBio
Against the background of the global health crisis, the first cycle of the PlayBeyondBio project ended today (Tuesday) - a fast track program to transform Israeli startups in the field of digital health into groundbreaking international companies
חיסון תרופה קורונה אילוסטרציה

As the Covid-19 vaccine arms race intensifies, big money is at risk

10.08.20|Sophie Shulman
Governments want to be among the first to get their hands on the coveted solution, but they are also risking money that could be used to strengthen their healthcare system
אסטרהזנקה חברת תרופות מטה בריטניה astrazeneca

Pharmaceutical Company AstraZeneca Launches Digital Health Program in Israel

27.11.19|Meir Orbach
Alongside funding, the program will provide Israeli startups with mentorship and training
לוויין עמוס 6

CTech’s Tuesday Roundup of Israeli Tech News

IDB’s bid for Israeli satellite operator Spacecom nearing closure. AstraZeneca signs deal with cancer immunotherapy company Compugen
ענת כהן-דייג מנכ"לית קומפיוג'ן

AstraZeneca Signs Deal with Cancer Immunotherapy Company Compugen

03.04.18|Lilach Baumer
The deal has the potential to be worth over $200 million for Nasdaq-listed Compugen
מנכ"ל AstraZeneca פסקל סוריו Pascal Soriot

Soriot's Teva Appointment Unlikely, Says Activist Investor

06.08.17|Golan Hazani
Teva’s board was surprised to learn AstraZeneca's CEO Pascal Soriot will not be joining the company. Teva activist investor Benny Landa called an early report on Teva's negotiations with Mr. Soriot "devastating"
מנכ"ל AstraZeneca פסקל סוריו Pascal Soriot

Teva in Talks to Appoint AstraZenca's Pascal Soriot as CEO

18.07.17|Golan Hazani
Mr. Soriot has met with the company’s search committee and its chairman and expressed his agreement to serve as its next CEO, people familiar with the matter said